Elan Pharmaceuticals, Inc.

Medimmune Limited

Elan Pharma International Limited

Jon Eric Hawkinson

Eugene D Thorsett

Michael A Pleiss

Francine S Grant

Louis Brogley

Michael S Dappen

Michael Ye

Ramesh Kasar

Sarah Bartulis

John Alan Tucker

Andrew Grier Buchanan

Matthew Alexander Sleeman

Philip Bland-Ward

Martin Neitzel

Albert George Thom

Fraser Welsh

Ruth Franks

Mohammed A Khan

Carl Anthony Matthews

Celia Patricia Hart

Ryan C Holcomb

Specific binding members for Nerve Growth Factor (NGF), in particular anti-NGF antibody molecules, especially human antibody molecules, and especially those that neutralize NGF activity. Methods for using anti-NGF antibody molecules in diagnosis or treatment of NGF related disorders, including pain, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, other diseases of airway inflammation, diabetic neuropathy, cardiac arrhythmias, HIV, arthritis, psoriasis and cancer.

Methods of treating neuropathic pain with specific binding members for NGF

Specific binding members for NGF

Disclosed are sulfonylquinoxalone acetamide derivatives useful as bradykinin antagonists.

Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists

Disclosed are sulfonylquinoxalone derivatives of the general formula: These compounds are useful as bradykinin antagonists.

Disclosed are 1-sulfonylquioxalone acetamides and derivatives thereof. The compounds are exemplified by compounds of the formula: Such compounds, derivatives and related compounds are useful as bradykinin antagonists.

Sulfonylquinoxalone derivatives as bradykinin antagonists

Growing community of inventors

Palo Alto, CA, United States of America

Jon Eric Hawkinson